Materia Medica Holding
Clinical trials sponsored by Materia Medica Holding, explained in plain language.
-
New cough syrup for kids tested in major flu season trial
Symptom relief Recruiting nowThis study tests whether a liquid medicine called Rengalin can safely reduce coughing in children aged 6 months to 3 years who have a viral cold or flu. About 264 children will receive either Rengalin or a placebo three times a day for 7 days. The main goal is to see if more chil…
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated May 26, 2026 06:17 UTC
-
New drug raphamin aims to shorten Kids' colds in major trial
Symptom relief Recruiting nowThis study tests whether a medicine called Raphamin helps children aged 3 to 12 recover faster from common colds and flu-like illnesses. About 374 children will receive either Raphamin or a placebo, and researchers will track how quickly symptoms like fever and stuffy nose go awa…
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated May 26, 2026 06:13 UTC
-
New drug raphamin aims to zap sinus pain in days
Symptom relief Recruiting nowThis study tests whether Raphamin can quickly relieve symptoms of acute sinus infections, like stuffy nose, headache, and facial pain. About 552 adults with early-stage sinusitis will receive either Raphamin or a placebo. The main goal is to see if symptoms improve significantly …
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC